HCPCS Index Logo

HCPCS Codes Alphabetical Index

— Q —  /  — Q0 —

Q0 — Investigational clinical service provided in a clinical research study that is in an approved clinical research study
Code added date: 20080101
Code effective date: 20080101
Q0 in HTML format HTML  |  Q0 in PDF (Portable Document Format) PDF  |  Q0 in plain Text format TXT
Q0035 — Cardiokymography
Code added date: 19890101
Code effective date: 19910101
Q0035 in HTML format HTML  |  Q0035 in PDF (Portable Document Format) PDF  |  Q0035 in plain Text format TXT
Q0081 — Infusion therapy, using other than chemotherapeutic drugs, per visit
Code added date: 19920101
Code effective date: 19960101
Q0081 in HTML format HTML  |  Q0081 in PDF (Portable Document Format) PDF  |  Q0081 in plain Text format TXT
Q0083 — Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit
Code added date: 19920101
Code effective date: 19960101
Q0083 in HTML format HTML  |  Q0083 in PDF (Portable Document Format) PDF  |  Q0083 in plain Text format TXT
Q0084 — Chemotherapy administration by infusion technique only, per visit
Code added date: 19920101
Code effective date: 19960101
Q0084 in HTML format HTML  |  Q0084 in PDF (Portable Document Format) PDF  |  Q0084 in plain Text format TXT
Q0085 — Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit
Code added date: 19920101
Code effective date: 19960101
Q0085 in HTML format HTML  |  Q0085 in PDF (Portable Document Format) PDF  |  Q0085 in plain Text format TXT
Q0090 — Levonorgestrel-releasing intrauterine contraceptive system, (skyla), 13.5 mg
Code added date: 20130701
Code effective date: 20140101
Q0090 in HTML format HTML  |  Q0090 in PDF (Portable Document Format) PDF  |  Q0090 in plain Text format TXT
Q0091 — Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory
Code added date: 19920101
Code effective date: 19960701
Q0091 in HTML format HTML  |  Q0091 in PDF (Portable Document Format) PDF  |  Q0091 in plain Text format TXT
Q0092 — Set-up portable x-ray equipment
Code added date: 19930101
Code effective date: 19960101
Q0092 in HTML format HTML  |  Q0092 in PDF (Portable Document Format) PDF  |  Q0092 in plain Text format TXT
Q0111 — Wet mounts, including preparations of vaginal, cervical or skin specimens
Code added date: 19940101
Code effective date: 20200101
Q0111 in HTML format HTML  |  Q0111 in PDF (Portable Document Format) PDF  |  Q0111 in plain Text format TXT
Q0112 — All potassium hydroxide (koh) preparations
Code added date: 19940101
Code effective date: 19940101
Q0112 in HTML format HTML  |  Q0112 in PDF (Portable Document Format) PDF  |  Q0112 in plain Text format TXT
Q0113 — Pinworm examinations
Code added date: 19940101
Code effective date: 19940101
Q0113 in HTML format HTML  |  Q0113 in PDF (Portable Document Format) PDF  |  Q0113 in plain Text format TXT
Q0114 — Fern test
Code added date: 19940101
Code effective date: 20200101
Q0114 in HTML format HTML  |  Q0114 in PDF (Portable Document Format) PDF  |  Q0114 in plain Text format TXT
Q0115 — Post-coital direct, qualitative examinations of vaginal or cervical mucous
Code added date: 19940101
Code effective date: 19940101
Q0115 in HTML format HTML  |  Q0115 in PDF (Portable Document Format) PDF  |  Q0115 in plain Text format TXT
Q0138 — Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Code added date: 20100101
Code effective date: 20100101
Q0138 in HTML format HTML  |  Q0138 in PDF (Portable Document Format) PDF  |  Q0138 in plain Text format TXT
Q0139 — Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
Code added date: 20100101
Code effective date: 20170101
Q0139 in HTML format HTML  |  Q0139 in PDF (Portable Document Format) PDF  |  Q0139 in plain Text format TXT
Q0144 — Azithromycin dihydrate, oral, capsules/powder, 1 gram
Code added date: 19960701
Code effective date: 20020701
Q0144 in HTML format HTML  |  Q0144 in PDF (Portable Document Format) PDF  |  Q0144 in plain Text format TXT
Q0155 — Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 20250101
Code effective date: 20250101
Q0155 in HTML format HTML  |  Q0155 in PDF (Portable Document Format) PDF  |  Q0155 in plain Text format TXT
Q0161 — Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 20140101
Code effective date: 20140101
Q0161 in HTML format HTML  |  Q0161 in PDF (Portable Document Format) PDF  |  Q0161 in plain Text format TXT
Q0162 — Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 20120101
Code effective date: 20120101
Q0162 in HTML format HTML  |  Q0162 in PDF (Portable Document Format) PDF  |  Q0162 in plain Text format TXT
Q0163 — Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0163 in HTML format HTML  |  Q0163 in PDF (Portable Document Format) PDF  |  Q0163 in plain Text format TXT
Q0164 — Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0164 in HTML format HTML  |  Q0164 in PDF (Portable Document Format) PDF  |  Q0164 in plain Text format TXT
Q0165 — Prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 20140101
Q0165 in HTML format HTML  |  Q0165 in PDF (Portable Document Format) PDF  |  Q0165 in plain Text format TXT
Q0166 — Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
Code added date: 19980401
Code effective date: 20090101
Q0166 in HTML format HTML  |  Q0166 in PDF (Portable Document Format) PDF  |  Q0166 in plain Text format TXT
Q0167 — Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0167 in HTML format HTML  |  Q0167 in PDF (Portable Document Format) PDF  |  Q0167 in plain Text format TXT
Q0168 — Dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 20140101
Q0168 in HTML format HTML  |  Q0168 in PDF (Portable Document Format) PDF  |  Q0168 in plain Text format TXT
Q0169 — Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0169 in HTML format HTML  |  Q0169 in PDF (Portable Document Format) PDF  |  Q0169 in plain Text format TXT
Q0170 — Promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 20140101
Q0170 in HTML format HTML  |  Q0170 in PDF (Portable Document Format) PDF  |  Q0170 in plain Text format TXT
Q0171 — Chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 20140101
Q0171 in HTML format HTML  |  Q0171 in PDF (Portable Document Format) PDF  |  Q0171 in plain Text format TXT
Q0172 — Chlorpromazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 20140101
Q0172 in HTML format HTML  |  Q0172 in PDF (Portable Document Format) PDF  |  Q0172 in plain Text format TXT
Q0173 — Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0173 in HTML format HTML  |  Q0173 in PDF (Portable Document Format) PDF  |  Q0173 in plain Text format TXT
Q0174 — Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0174 in HTML format HTML  |  Q0174 in PDF (Portable Document Format) PDF  |  Q0174 in plain Text format TXT
Q0175 — Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0175 in HTML format HTML  |  Q0175 in PDF (Portable Document Format) PDF  |  Q0175 in plain Text format TXT
Q0176 — Perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 20140101
Q0176 in HTML format HTML  |  Q0176 in PDF (Portable Document Format) PDF  |  Q0176 in plain Text format TXT
Q0177 — Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0177 in HTML format HTML  |  Q0177 in PDF (Portable Document Format) PDF  |  Q0177 in plain Text format TXT
Q0178 — Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 20140101
Q0178 in HTML format HTML  |  Q0178 in PDF (Portable Document Format) PDF  |  Q0178 in plain Text format TXT
Q0180 — Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0180 in HTML format HTML  |  Q0180 in PDF (Portable Document Format) PDF  |  Q0180 in plain Text format TXT
Q0181 — Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Code added date: 19980401
Code effective date: 19980401
Q0181 in HTML format HTML  |  Q0181 in PDF (Portable Document Format) PDF  |  Q0181 in plain Text format TXT
Q0220 — Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg
Code added date: 20211208
Code effective date: 20241213
Q0220 in HTML format HTML  |  Q0220 in PDF (Portable Document Format) PDF  |  Q0220 in plain Text format TXT
Q0221 — Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg
Code added date: 20220224
Code effective date: 20241213
Q0221 in HTML format HTML  |  Q0221 in PDF (Portable Document Format) PDF  |  Q0221 in plain Text format TXT
Q0222 — Injection, bebtelovimab, 175 mg
Code added date: 20220211
Code effective date: 20241213
Q0222 in HTML format HTML  |  Q0222 in PDF (Portable Document Format) PDF  |  Q0222 in plain Text format TXT
Q0224 — Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg
Code added date: 20240322
Code effective date: 20240322
Q0224 in HTML format HTML  |  Q0224 in PDF (Portable Document Format) PDF  |  Q0224 in plain Text format TXT
Q0235 — Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg
Code added date: 20251001
Code effective date: 20251001
Q0235 in HTML format HTML  |  Q0235 in PDF (Portable Document Format) PDF  |  Q0235 in plain Text format TXT
Q0237 — Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
Code added date: 20250124
Code effective date: 20250124
Q0237 in HTML format HTML  |  Q0237 in PDF (Portable Document Format) PDF  |  Q0237 in plain Text format TXT
Q0239 — Injection, bamlanivimab-xxxx, 700 mg
Code added date: 20201109
Code effective date: 20210417
Q0239 in HTML format HTML  |  Q0239 in PDF (Portable Document Format) PDF  |  Q0239 in plain Text format TXT
Q0240 — Injection, casirivimab and imdevimab, 600 mg
Code added date: 20210730
Code effective date: 20241213
Q0240 in HTML format HTML  |  Q0240 in PDF (Portable Document Format) PDF  |  Q0240 in plain Text format TXT
Q0243 — Injection, casirivimab and imdevimab, 2400 mg
Code added date: 20201121
Code effective date: 20241213
Q0243 in HTML format HTML  |  Q0243 in PDF (Portable Document Format) PDF  |  Q0243 in plain Text format TXT
Q0244 — Injection, casirivimab and imdevimab, 1200 mg
Code added date: 20210603
Code effective date: 20241213
Q0244 in HTML format HTML  |  Q0244 in PDF (Portable Document Format) PDF  |  Q0244 in plain Text format TXT
Q0245 — Injection, bamlanivimab and etesevimab, 2100 mg
Code added date: 20210209
Code effective date: 20231214
Q0245 in HTML format HTML  |  Q0245 in PDF (Portable Document Format) PDF  |  Q0245 in plain Text format TXT
Q0247 — Injection, sotrovimab, 500 mg
Code added date: 20210526
Code effective date: 20241213
Q0247 in HTML format HTML  |  Q0247 in PDF (Portable Document Format) PDF  |  Q0247 in plain Text format TXT
Q0249 — Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
Code added date: 20210624
Code effective date: 20210624
Q0249 in HTML format HTML  |  Q0249 in PDF (Portable Document Format) PDF  |  Q0249 in plain Text format TXT
Q0477 — Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20180101
Code effective date: 20180101
Q0477 in HTML format HTML  |  Q0477 in PDF (Portable Document Format) PDF  |  Q0477 in plain Text format TXT
Q0478 — Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type
Code added date: 20110101
Code effective date: 20130101
Q0478 in HTML format HTML  |  Q0478 in PDF (Portable Document Format) PDF  |  Q0478 in plain Text format TXT
Q0479 — Power module for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20110101
Code effective date: 20130101
Q0479 in HTML format HTML  |  Q0479 in PDF (Portable Document Format) PDF  |  Q0479 in plain Text format TXT
Q0480 — Driver for use with pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0480 in HTML format HTML  |  Q0480 in PDF (Portable Document Format) PDF  |  Q0480 in plain Text format TXT
Q0481 — Microprocessor control unit for use with electric ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0481 in HTML format HTML  |  Q0481 in PDF (Portable Document Format) PDF  |  Q0481 in plain Text format TXT
Q0482 — Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0482 in HTML format HTML  |  Q0482 in PDF (Portable Document Format) PDF  |  Q0482 in plain Text format TXT
Q0483 — Monitor/display module for use with electric ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0483 in HTML format HTML  |  Q0483 in PDF (Portable Document Format) PDF  |  Q0483 in plain Text format TXT
Q0484 — Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0484 in HTML format HTML  |  Q0484 in PDF (Portable Document Format) PDF  |  Q0484 in plain Text format TXT
Q0485 — Monitor control cable for use with electric ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0485 in HTML format HTML  |  Q0485 in PDF (Portable Document Format) PDF  |  Q0485 in plain Text format TXT
Q0486 — Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0486 in HTML format HTML  |  Q0486 in PDF (Portable Document Format) PDF  |  Q0486 in plain Text format TXT
Q0487 — Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0487 in HTML format HTML  |  Q0487 in PDF (Portable Document Format) PDF  |  Q0487 in plain Text format TXT
Q0488 — Power pack base for use with electric ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0488 in HTML format HTML  |  Q0488 in PDF (Portable Document Format) PDF  |  Q0488 in plain Text format TXT
Q0489 — Power pack base for use with electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0489 in HTML format HTML  |  Q0489 in PDF (Portable Document Format) PDF  |  Q0489 in plain Text format TXT
Q0490 — Emergency power source for use with electric ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0490 in HTML format HTML  |  Q0490 in PDF (Portable Document Format) PDF  |  Q0490 in plain Text format TXT
Q0491 — Emergency power source for use with electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0491 in HTML format HTML  |  Q0491 in PDF (Portable Document Format) PDF  |  Q0491 in plain Text format TXT
Q0492 — Emergency power supply cable for use with electric ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0492 in HTML format HTML  |  Q0492 in PDF (Portable Document Format) PDF  |  Q0492 in plain Text format TXT
Q0493 — Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0493 in HTML format HTML  |  Q0493 in PDF (Portable Document Format) PDF  |  Q0493 in plain Text format TXT
Q0494 — Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0494 in HTML format HTML  |  Q0494 in PDF (Portable Document Format) PDF  |  Q0494 in plain Text format TXT
Q0495 — Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0495 in HTML format HTML  |  Q0495 in PDF (Portable Document Format) PDF  |  Q0495 in plain Text format TXT
Q0496 — Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0496 in HTML format HTML  |  Q0496 in PDF (Portable Document Format) PDF  |  Q0496 in plain Text format TXT
Q0497 — Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0497 in HTML format HTML  |  Q0497 in PDF (Portable Document Format) PDF  |  Q0497 in plain Text format TXT
Q0498 — Holster for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0498 in HTML format HTML  |  Q0498 in PDF (Portable Document Format) PDF  |  Q0498 in plain Text format TXT
Q0499 — Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0499 in HTML format HTML  |  Q0499 in PDF (Portable Document Format) PDF  |  Q0499 in plain Text format TXT
Q0500 — Filters for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0500 in HTML format HTML  |  Q0500 in PDF (Portable Document Format) PDF  |  Q0500 in plain Text format TXT
Q0501 — Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0501 in HTML format HTML  |  Q0501 in PDF (Portable Document Format) PDF  |  Q0501 in plain Text format TXT
Q0502 — Mobility cart for pneumatic ventricular assist device, replacement only
Code added date: 20051001
Code effective date: 20130101
Q0502 in HTML format HTML  |  Q0502 in PDF (Portable Document Format) PDF  |  Q0502 in plain Text format TXT
Q0503 — Battery for pneumatic ventricular assist device, replacement only, each
Code added date: 20051001
Code effective date: 20130101
Q0503 in HTML format HTML  |  Q0503 in PDF (Portable Document Format) PDF  |  Q0503 in plain Text format TXT
Q0504 — Power adapter for pneumatic ventricular assist device, replacement only, vehicle type
Code added date: 20051001
Code effective date: 20130101
Q0504 in HTML format HTML  |  Q0504 in PDF (Portable Document Format) PDF  |  Q0504 in plain Text format TXT
Q0505 — Miscellaneous supply or accessory for use with ventricular assist device
Code added date: 20051001
Code effective date: 20130401
Q0505 in HTML format HTML  |  Q0505 in PDF (Portable Document Format) PDF  |  Q0505 in plain Text format TXT
Q0506 — Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
Code added date: 20100101
Code effective date: 20130101
Q0506 in HTML format HTML  |  Q0506 in PDF (Portable Document Format) PDF  |  Q0506 in plain Text format TXT
Q0507 — Miscellaneous supply or accessory for use with an external ventricular assist device
Code added date: 20130401
Code effective date: 20130401
Q0507 in HTML format HTML  |  Q0507 in PDF (Portable Document Format) PDF  |  Q0507 in plain Text format TXT
Q0508 — Miscellaneous supply or accessory for use with an implanted ventricular assist device
Code added date: 20130401
Code effective date: 20130401
Q0508 in HTML format HTML  |  Q0508 in PDF (Portable Document Format) PDF  |  Q0508 in plain Text format TXT
Q0509 — Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
Code added date: 20130401
Code effective date: 20130401
Q0509 in HTML format HTML  |  Q0509 in PDF (Portable Document Format) PDF  |  Q0509 in plain Text format TXT
Q0510 — Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
Code added date: 20060101
Code effective date: 20060101
Q0510 in HTML format HTML  |  Q0510 in PDF (Portable Document Format) PDF  |  Q0510 in plain Text format TXT
Q0511 — Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
Code added date: 20060101
Code effective date: 20060101
Q0511 in HTML format HTML  |  Q0511 in PDF (Portable Document Format) PDF  |  Q0511 in plain Text format TXT
Q0512 — Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
Code added date: 20060101
Code effective date: 20090101
Q0512 in HTML format HTML  |  Q0512 in PDF (Portable Document Format) PDF  |  Q0512 in plain Text format TXT
Q0513 — Pharmacy dispensing fee for inhalation drug(s); per 30 days
Code added date: 20060101
Code effective date: 20060101
Q0513 in HTML format HTML  |  Q0513 in PDF (Portable Document Format) PDF  |  Q0513 in plain Text format TXT
Q0514 — Pharmacy dispensing fee for inhalation drug(s); per 90 days
Code added date: 20060101
Code effective date: 20060101
Q0514 in HTML format HTML  |  Q0514 in PDF (Portable Document Format) PDF  |  Q0514 in plain Text format TXT
Q0515 — Injection, sermorelin acetate, 1 microgram
Code added date: 20060101
Code effective date: 20060101
Q0515 in HTML format HTML  |  Q0515 in PDF (Portable Document Format) PDF  |  Q0515 in plain Text format TXT
Q0516 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days
Code added date: 20240102
Code effective date: 20250101
Q0516 in HTML format HTML  |  Q0516 in PDF (Portable Document Format) PDF  |  Q0516 in plain Text format TXT
Q0517 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days
Code added date: 20240102
Code effective date: 20250101
Q0517 in HTML format HTML  |  Q0517 in PDF (Portable Document Format) PDF  |  Q0517 in plain Text format TXT
Q0518 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days
Code added date: 20240102
Code effective date: 20250101
Q0518 in HTML format HTML  |  Q0518 in PDF (Portable Document Format) PDF  |  Q0518 in plain Text format TXT
Q0519 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days
Code added date: 20240915
Code effective date: 20250101
Q0519 in HTML format HTML  |  Q0519 in PDF (Portable Document Format) PDF  |  Q0519 in plain Text format TXT
Q0520 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days
Code added date: 20240915
Code effective date: 20250101
Q0520 in HTML format HTML  |  Q0520 in PDF (Portable Document Format) PDF  |  Q0520 in plain Text format TXT
Q0521 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
Code added date: 20250101
Code effective date: 20250101
Q0521 in HTML format HTML  |  Q0521 in PDF (Portable Document Format) PDF  |  Q0521 in plain Text format TXT